Upstream Bio (UPB) Other financing activities (2024 - 2026)

Upstream Bio's Other financing activities history runs 3 years deep, the most recent figure standing at $598000.0 for Q1 2026.

• In Q1 2026, Other financing activities changed N/A year-over-year to $598000.0; the TTM figure through Mar 2026 stood at $794000.0 (down 99.71% YoY), while the FY2025 annual figure was $196000.0, down 99.93% from the prior year.
• Other financing activities for Q1 2026 stood at $598000.0, up from -$1.2 million in the prior quarter.
• The five-year high for Other financing activities was $272.6 million in Q4 2024, with the low at -$1.2 million in Q4 2025.
• The 3-year median for Other financing activities is $349000.0 (2024), against an average of $34.2 million.
• Peak annual rise in Other financing activities reached 3900.0% in 2025, while the deepest fall reached 100.43% in 2025.
• Upstream Bio's Other financing activities stood at $272.6 million in 2024, then sank by 100.43% to -$1.2 million in 2025, then jumped by 150.85% to $598000.0 in 2026.
• Business Quant data shows UPB's Other financing activities at $598000.0 in Q1 2026, -$1.2 million in Q4 2025, and $760000.0 in Q3 2025.